MIAMI, April 12, 2011 /PRNewswire/ -- Double Eagle Holdings, Ltd. (Pink Sheets: DEGH) DOUBLE EAGLE HOLDINGS, LTD. INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER
As used in this Information Statement, the terms "our company," "we" and "us" refer to Double Eagle Holdings, Ltd., a Nevada corporation. This Information Statement is being mailed on or about April 18, 2011, by us to the holders of record of our shares of common stock as of the close of business on April 7, 2011. This Information Statement is provided to you for information purposes only. We are not soliciting proxies in connection with the matters described in this Information Statement. You are urged to read this Information Statement carefully. You are not, however, required to take any action.
Our company, directors and officers of our company are currently negotiating the terms of an Exchange Agreement with various third parties whereby it is anticipated that, upon the closing of the proposed Exchange Agreement, we will issue an aggregate of 23,297,000 shares of our common stock in exchange for all of the outstanding shares of common stock of Fuse Science, Inc. ("Fuse Science"), such that Fuse Science will become a wholly owned subsidiary of ours. The terms of the proposed Exchange Agreement are summarized below under the heading "Exchange Agreement."
Our current board of directors consists of Aitan Zacharin, Maurice E. Durschlag and Erik Phillips. The proposed Exchange Agreement contemplates that, upon the closing thereof, Mr. Durschlag and Mr. Phillips will resign as directors and be replaced by Adam Adler and Brian Tuffin, each of whom are current shareholders of Fuse Science. The resignations of the current directors, appointments of Mr. Adler and Mr. Tuffin will constitute a change in the majority of our directors. The resignations and appointments of such directors, however, will not take effect until at least ten days after this Information Statement is filed with the Securities and Exchange Commission and mailed to our shareholders of record in compliance with Section 14(f) of the Securities Exchange Act of 1934, and Rule 14(f)-1 there under.
Fuse Science, Inc. has developed several concentrated sublingual drops to include electrolytes for sports, energy drops for stamina, vitamin & nutrition drops for children, etc. Fuse Science, Inc. also has a patent-pending trans-dermal technology incorporating active ingredients that when applied in conjunction with heat and moisture increase the overall health and beauty of the skin and can formulate for acne treatment.
For more information: http://fusescience.com/
Liza M Santana | 305.968.2384
SOURCE Double Eagle Holdings, Ltd.